固体瘤微环境和相关的向策略:简要的回顾
Yingliang Wang1,2,3, Huimin Zhou4, Shuguang Ju1,2,3
1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in immunology
|April 10, 2025
概括
这项研究将瘤微环境 (TME) 分类为物理,机械,代谢,炎症和免疫组件. 了解这些TME特征对于开发新的癌症疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤微环境 (TME) 极大地影响瘤的进展,包括增殖,亡抵抗,免疫逃避和转移.
- 尽管它很重要,但对TME组件特征及其相互关系缺乏深入的理解.
- 针对TME需要对其组成部分及其在瘤生长中的作用有全面的了解.
研究的目的:
- 创新地将TME分为不同的物理,机械,代谢,炎症和免疫微环境.
- 阐明每个TME组件的特性及其检测方法.
- 突出目前的治疗策略,潜在的目标,挑战和TME研究的未来方向.
主要方法:
- 将TME分为五个主要类别:物理,机械,代谢,炎症和免疫.
- 描述单个TME组件的特征.
- 目前用于TME成分的检测方法的概述.
- 审查针对TME的现有和潜在的治疗策略.
主要成果:
- 引入了一个新的,全面的TME分类系统.
- 提供了物理,机械,代谢,炎症和免疫微环境特征的详细描述.
- 突出了TME当前的策略和潜在的治疗目标.
结论:
- 对TME组件及其相互作用的更深入的理解对于有效的癌症治疗至关重要.
- 拟议的分类为TME向治疗的未来研究和临床应用提供了一个框架.
- 解决TME研究当前的挑战将带来显著的临床益处,并推进癌症治疗策略.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


